Health In Tech Sees FY2026 Sales $45.000M-$50.000M vs $42.035M Est

Benzinga Newsdesk www.benzinga.com Positive 78.6%

Neg 0% Neu 0% Pos 78.6%

Health In Tech (NASDAQ:HIT) sees FY2026 sales of $45.000 million-$50.000 million vs $42.035 million analyst estimate.

Comments

No comments yet. Be the first!